drugset / Trial / NCT01291901
NP2 Enkephalin For Treatment of Intractable Cancer Pain
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to examine the impact of intradermal delivery of NP2 on pain scores and pain medication usage in subjects with intractable pain due to malignant disease. A second purpose is to confirm safety and secondary efficacy measurements.
Timeline
- Start
- 2011-01
- Primary completion
- 2012-07
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NP2 | Unknown | 1 ml | Intrathecal |